DE60025403D1 - Kit zur behandlung von malaria die chloroquin und bulaquin enthält - Google Patents

Kit zur behandlung von malaria die chloroquin und bulaquin enthält

Info

Publication number
DE60025403D1
DE60025403D1 DE60025403T DE60025403T DE60025403D1 DE 60025403 D1 DE60025403 D1 DE 60025403D1 DE 60025403 T DE60025403 T DE 60025403T DE 60025403 T DE60025403 T DE 60025403T DE 60025403 D1 DE60025403 D1 DE 60025403D1
Authority
DE
Germany
Prior art keywords
bulaquin
chloroquin
kit
treatment
malaria containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025403T
Other languages
English (en)
Other versions
DE60025403T2 (de
Inventor
Francis Joseph Pinto
Swati Ajay Piramal
Ram Pratap
Amiya Prasad Bhaduri
Harsh Pati Thapliyal
Sunil Kumar Puri
Guru Prasad Dutta
Anil Kumar Dwivedi
Satyawan Singh
Pratima Srivastava
Vikash Chandra Pandey
Sudhir Srivastava
Shio Kumar Singh
Ram Chandra Gupta
Jagdishwar Sahai Srivastava
Omkar Prasad Asthana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Piramal Enterprises Ltd
Original Assignee
Council of Scientific and Industrial Research CSIR
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR, Nicholas Piramal India Ltd filed Critical Council of Scientific and Industrial Research CSIR
Publication of DE60025403D1 publication Critical patent/DE60025403D1/de
Application granted granted Critical
Publication of DE60025403T2 publication Critical patent/DE60025403T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60025403T 2000-05-31 2000-08-30 Kit zur behandlung von malaria die chloroquin und bulaquin enthält Expired - Lifetime DE60025403T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31
INMU05012000 2000-05-31
PCT/IN2000/000081 WO2001091535A2 (en) 2000-05-31 2000-08-30 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält

Publications (2)

Publication Number Publication Date
DE60025403D1 true DE60025403D1 (de) 2006-03-30
DE60025403T2 DE60025403T2 (de) 2006-08-24

Family

ID=11097250

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0001292306T Pending DE00993875T1 (de) 2000-05-31 2000-08-30 Kit zur behandlung von malaria die chloroquin und 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält
DE60025403T Expired - Lifetime DE60025403T2 (de) 2000-05-31 2000-08-30 Kit zur behandlung von malaria die chloroquin und bulaquin enthält

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0001292306T Pending DE00993875T1 (de) 2000-05-31 2000-08-30 Kit zur behandlung von malaria die chloroquin und 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält

Country Status (28)

Country Link
US (1) US7404962B1 (de)
EP (1) EP1292306B1 (de)
JP (1) JP2004505017A (de)
KR (1) KR20030025926A (de)
AP (1) AP1435A (de)
AR (1) AR028458A1 (de)
AT (1) ATE314848T1 (de)
AU (2) AU2879001A (de)
BR (1) BR0005247A (de)
CA (1) CA2413775C (de)
CR (1) CR6835A (de)
CZ (1) CZ296875B6 (de)
DE (2) DE00993875T1 (de)
DK (1) DK1292306T3 (de)
EC (1) ECSP003694A (de)
ES (1) ES2200729T3 (de)
GT (1) GT200000187A (de)
HK (1) HK1052467B (de)
HN (1) HN2001000118A (de)
HU (1) HUP0301925A3 (de)
MX (1) MXPA02011883A (de)
NO (1) NO324774B1 (de)
OA (1) OA12276A (de)
PE (1) PE20011319A1 (de)
PL (1) PL200748B1 (de)
SV (1) SV2002000201A (de)
WO (1) WO2001091535A2 (de)
ZA (1) ZA200209726B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008135762A (ru) * 2006-02-16 2010-03-27 Де МакЛин Хоспитал Корпорейшн (US) Способы и композиции для лечения болезни паркинсона
US8658648B2 (en) 2008-12-05 2014-02-25 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
NZ246606A (en) * 1992-02-07 1995-09-26 Ciba Geigy Ag Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof

Also Published As

Publication number Publication date
CZ296875B6 (cs) 2006-07-12
DK1292306T3 (da) 2006-05-22
PL372718A1 (en) 2005-07-25
ZA200209726B (en) 2004-03-10
OA12276A (en) 2006-05-10
WO2001091535A2 (en) 2001-12-06
AR028458A1 (es) 2003-05-07
NO20025765D0 (no) 2002-11-29
HUP0301925A3 (en) 2009-03-30
AP1435A (en) 2005-06-21
AP2002002672A0 (en) 2002-12-31
AU2879001A (en) 2001-12-11
US7404962B1 (en) 2008-07-29
HK1052467B (zh) 2006-03-10
DE00993875T1 (de) 2004-04-15
EP1292306A2 (de) 2003-03-19
SV2002000201A (es) 2002-10-24
WO2001091535B1 (en) 2002-10-31
NO20025765L (no) 2003-01-08
CR6835A (es) 2007-04-26
KR20030025926A (ko) 2003-03-29
GT200000187A (es) 2002-04-18
ECSP003694A (es) 2002-01-25
AU2001228790B2 (en) 2007-02-01
HUP0301925A2 (hu) 2003-09-29
NO324774B1 (no) 2007-12-10
HN2001000118A (es) 2001-10-29
CA2413775A1 (en) 2001-12-06
CZ20024071A3 (cs) 2003-04-16
PE20011319A1 (es) 2002-03-02
MXPA02011883A (es) 2004-05-17
BR0005247A (pt) 2002-02-13
WO2001091535A3 (en) 2002-07-04
HK1052467A1 (en) 2003-09-19
EP1292306B1 (de) 2006-01-04
ES2200729T1 (es) 2004-03-16
JP2004505017A (ja) 2004-02-19
PL200748B1 (pl) 2009-02-27
ATE314848T1 (de) 2006-02-15
ES2200729T3 (es) 2006-07-16
DE60025403T2 (de) 2006-08-24
CA2413775C (en) 2009-08-25

Similar Documents

Publication Publication Date Title
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60224163D1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
ATE323661T1 (de) Behandlung von mineralischen stoffen
ATE376994T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE50214540D1 (de) Stanz bei der behandlung von wunden
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
DE60204951D1 (de) Ccr5 antagonisten verwendbar für die behandlung von aids
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
DE60030554D1 (de) Verwendungen von et743 zur behandlung von krebs
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition